Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Amicone

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 13, 2020
[Tolvaptan in ADPKD: a turning point or an unsustainable therapy? One year of "real life" experience]Maria Amicone, Eleonora Riccio, Valentina Angelucci, et al.
Journal of Nephrology|May 19, 2021
Therapeutic advances in ADPKD: the future awaitsIvana Capuano, Pasquale Buonanno, Eleonora Riccio, et al.
Kidney & Blood Pressure Research|February 10, 2025
Atheroembolic Kidney Disease and Atypical Hemolytic Uremic Syndrome: Two Sides of the Same Coin?Antonio Pisani, Pasquale Buonanno, Maria Amicone, et al.
Journal of Nephrology|November 6, 2024
Octreotide-LAR in ADPKD patients with very low kidney function: a single-center real-life experienceEleonora Riccio, Maria Amicone, Ivana Capuano, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 2023
Home-based exercise in patients on maintenance dialysis: a systematic review and meta-analysis of randomized clinical trialsYuri Battaglia, Maria Amicone, Alessandro Mantovani, et al.
Epigenomics|April 3, 2026
miRNA profiling of a mutation-negative PKD cohort reveals PKD1/PKD2 ADPKD shared signatures and differencesBruna De Felice, Ersilia Nigro, Maria Amicone, et al.
Clinical Nephrology|December 22, 2022
Familial polycystic kidneys with no genetic confirmation: Are we sure it is ADPKD?Manuela Rizzo, Ilaria Pezone, Maria Amicone, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 29, 2023
[Type I Hyperprolinemia - What about the Kidney?]Manuela Rizzo, Maria Amicone, Maria Luigia Sellitti, et al.
Frontiers in Cardiovascular Medicine|February 28, 2022
RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective StudyEleonora Riccio, Ivana Capuano, Pasquale Buonanno, et al.
Molecular Genetics & Genomic Medicine|March 23, 2021
Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocolEleonora Riccio, Mario Zanfardino, Monica Franzese, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|June 13, 2020
[Tolvaptan in ADPKD: a turning point or an unsustainable therapy? One year of "real life" experience]Maria Amicone, Eleonora Riccio, Valentina Angelucci, et al.
Journal of Nephrology|May 19, 2021
Therapeutic advances in ADPKD: the future awaitsIvana Capuano, Pasquale Buonanno, Eleonora Riccio, et al.
Kidney & Blood Pressure Research|February 10, 2025
Atheroembolic Kidney Disease and Atypical Hemolytic Uremic Syndrome: Two Sides of the Same Coin?Antonio Pisani, Pasquale Buonanno, Maria Amicone, et al.
Journal of Nephrology|November 6, 2024
Octreotide-LAR in ADPKD patients with very low kidney function: a single-center real-life experienceEleonora Riccio, Maria Amicone, Ivana Capuano, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 18, 2023
Home-based exercise in patients on maintenance dialysis: a systematic review and meta-analysis of randomized clinical trialsYuri Battaglia, Maria Amicone, Alessandro Mantovani, et al.
Epigenomics|April 3, 2026
miRNA profiling of a mutation-negative PKD cohort reveals PKD1/PKD2 ADPKD shared signatures and differencesBruna De Felice, Ersilia Nigro, Maria Amicone, et al.
Clinical Nephrology|December 22, 2022
Familial polycystic kidneys with no genetic confirmation: Are we sure it is ADPKD?Manuela Rizzo, Ilaria Pezone, Maria Amicone, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|December 29, 2023
[Type I Hyperprolinemia - What about the Kidney?]Manuela Rizzo, Maria Amicone, Maria Luigia Sellitti, et al.
Frontiers in Cardiovascular Medicine|February 28, 2022
RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective StudyEleonora Riccio, Ivana Capuano, Pasquale Buonanno, et al.
Molecular Genetics & Genomic Medicine|March 23, 2021
Stepwise shortening of agalsidase beta infusion duration in Fabry disease: Clinical experience with infusion rate escalation protocolEleonora Riccio, Mario Zanfardino, Monica Franzese, et al.
Pageof 3